Real-world study reveals how many hive patients need a xolair boost
NCT ID NCT04583475
First seen Jan 06, 2026 · Last updated May 25, 2026 · Updated 16 times
Summary
This study looked at 163 adults with chronic spontaneous urticaria (long-term hives) to see how many needed a higher dose or more frequent injections of the drug Xolair (omalizumab) after 3 months. Researchers simply observed what doctors prescribed in real life, without giving any treatment themselves. The goal was to understand real-world treatment patterns, not to test a new therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPONTANEOUS URTICARIA, CHRONIC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hop Claude Huriez Chu Lille
Lille, 59037, France
Conditions
Explore the condition pages connected to this study.